default author photo

David J. Venzon

National Cancer Institute - Biostatistics and Data Management Section

9609 Medical Center Drive

Rockville, MD 20850

United States

SCHOLARLY PAPERS

2

DOWNLOADS

95

TOTAL CITATIONS

1

Scholarly Papers (2)

1.

Sequential Analysis of Binding and Neutralizing Antibody in COVID-19 Convalescent Patients at 14 Months After SARS-CoV-2 Infection

Number of pages: 36 Posted: 11 Oct 2021
National Cancer Institute at Frederick - Human Retrovirus Section, National and Kapodistrian University of Athens - Department of Clinical Therapeutics, - Department of Clinical Therapeutics, National Cancer Institute at Frederick - Human Retrovirus Pathogenesis Section, National Cancer Institute at Frederick - Human Retrovirus Pathogenesis Section, National Cancer Institute at Frederick - Human Retrovirus Pathogenesis Section, National Cancer Institute at Frederick - Human Retrovirus Pathogenesis Section, - Department of Clinical Therapeutics, Frederick National Laboratory for Cancer Research - MS Applied Information and Management Sciences, National Cancer Institute - Biostatistics and Data Management Section, National and Kapodistrian University of Athens Medical School - Hematology and Oncology Unit, National Cancer Institute at Frederick - Human Retrovirus Section and National Cancer Institute at Frederick - Human Retrovirus Pathogenesis Section
Downloads 62 (942,565)
Citation 1

Abstract:

Loading...

Durability, longevity, COVID-19, antibody, kinetics, SARS-CoV-2 variant, neutralization, anamnestic response, recall, re-exposure, Spike, Nucleocapsid, Spike-RBD, variants of concern, Alfa, Beta, Delta, Mu

2.

Anti-V2 Antibodies Virus Vulnerability Revealed by Envelope V1 Deletion in HIV Vaccine Candidates

Number of pages: 87 Posted: 21 Oct 2020
National Cancer Institute - Animal Models and Retroviral Vaccines Section, National Cancer Institute - Animal Models and Retroviral Vaccines Section, National Institutes of Health - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Cancer Institute - Animal Models and Retroviral Vaccines Section, National Cancer Institute - Immune Biology of Retroviral Infection Section, National Institutes of Health (NIH) - Section on Intercellular Interactions, Advanced Bioscience Laboratories, Advanced Bioscience Laboratories, New York University (NYU) - NYU Langone Health, New York University (NYU) - NYU Langone Health, Government of the United States of America - Henry M. Jackson Foundation for the Advancement of Military Medicine, Government of the United States of America - Henry M. Jackson Foundation for the Advancement of Military Medicine, Walter Reed Army Institute of Research - U.S. Military HIV Research Program, National Institutes of Health (NIH) - Laboratory of Immunoregulation, National Institutes of Health (NIH) - Laboratory of Immunoregulation, Walter Reed Army Institute of Research - U.S. Military HIV Research Program, Government of the United States of America - Henry M. Jackson Foundation for the Advancement of Military Medicine, Duke University - Division of Surgical Sciences, Duke University - Division of Surgical Sciences, National Institutes of Health (NIH) - Structural Biology Section, National Institutes of Health - Vaccine Research Center, National Institutes of Health (NIH) - ImmunoTechnology Section, National Institutes of Health (NIH) - ImmunoTechnology Section, National Institutes of Health (NIH) - ImmunoTechnology Section, National Cancer Institute - Animal Models and Retroviral Vaccines Section, National Cancer Institute - Animal Models and Retroviral Vaccines Section, National Institutes of Health (NIH) - Laboratory of Immunoregulation, National Cancer Institute - Animal Models and Retroviral Vaccines Section, National Cancer Institute - Animal Models and Retroviral Vaccines Section, National Cancer Institute - Animal Models and Retroviral Vaccines Section, National Cancer Institute - Animal Models and Retroviral Vaccines Section, National Cancer Institute - Animal Models and Retroviral Vaccines Section, National Cancer Institute - Animal Models and Retroviral Vaccines Section, National Cancer Institute - Animal Models and Retroviral Vaccines Section, Duke University - Department of Surgery, Duke University - Division of Surgical Sciences, Duke University - Medical Center, Duke University - Duke Human Vaccine Institute, National Cancer Institute at Frederick - Human Retrovirus Section, National Cancer Institute at Frederick - Human Retrovirus Pathogenesis Section, National Cancer Institute at Frederick - Human Retrovirus Section, National Cancer Institute - Biostatistics and Data Management Section, Frederick National Laboratory - AIDS and Cancer Virus Program, Frederick National Laboratory - AIDS and Cancer Virus Program, Frederick National Laboratory - AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research - AIDS and Cancer Virus Program, Walter Reed Army Institute of Research - U.S. Military HIV Research Program, National Institutes of Health (NIH) - Laboratory of Immunoregulation, National Institutes of Health (NIH) - Laboratory of Immunoregulation, Duke University - Division of Surgical Sciences, National Institutes of Health (NIH) - Section on Intercellular Interactions, National Cancer Institute - Immune Biology of Retroviral Infection Section, National Institutes of Health - Vaccine Research Center, National Institutes of Health (NIH) - ImmunoTechnology Section, Walter Reed Army Institute of Research - U.S. Military HIV Research Program, New York University (NYU) - NYU Langone Health and Medical University of Bialystok - Centre for Bioinformatics and Data Analysis
Downloads 33 (1,277,121)

Abstract:

Loading...

HIV, SIV, V1/V2, V1, ALVAC